Abstract
HaemophiliaVolume 27, Issue 4 p. e517-e519 LETTER TO THE EDITOR Primary thromboprophylaxis in a patient with type 3 von Willebrand disease and severe COVID-19 infection Anshul Vagrecha, Corresponding Author Anshul Vagrecha avagrecha@northwell.edu orcid.org/0000-0001-9095-7575 Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA Correspondence Anshul Vagrecha, Cohen Children's Medical Center, 269- 01 76th Avenue, Suite 255, New Hyde Park, NY 11040. Email: avagrecha@northwell.eduSearch for more papers by this authorJoseph Stanco, Joseph Stanco Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USASearch for more papers by this authorSumreen Majeed, Sumreen Majeed Northwell Health Cancer Institute, Imbert Cancer Center, Bay Shore, NY, USASearch for more papers by this authorPeter Kouides, Peter Kouides Mary M. Gooley Hemophilia Center, University of Rochester School of Medicine, Rochester, NY, USASearch for more papers by this authorSuchitra S. Acharya, Suchitra S. Acharya Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USASearch for more papers by this author Anshul Vagrecha, Corresponding Author Anshul Vagrecha avagrecha@northwell.edu orcid.org/0000-0001-9095-7575 Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA Correspondence Anshul Vagrecha, Cohen Children's Medical Center, 269- 01 76th Avenue, Suite 255, New Hyde Park, NY 11040. Email: avagrecha@northwell.eduSearch for more papers by this authorJoseph Stanco, Joseph Stanco Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USASearch for more papers by this authorSumreen Majeed, Sumreen Majeed Northwell Health Cancer Institute, Imbert Cancer Center, Bay Shore, NY, USASearch for more papers by this authorPeter Kouides, Peter Kouides Mary M. Gooley Hemophilia Center, University of Rochester School of Medicine, Rochester, NY, USASearch for more papers by this authorSuchitra S. Acharya, Suchitra S. Acharya Division of Hematology/Oncology and Cellular Therapy, Department of Pediatrics, Cohen Children's Medical Center, New Hyde Park, NY, USA Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USASearch for more papers by this author First published: 11 January 2021 https://doi.org/10.1111/hae.14252Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume27, Issue4July 2021Pages e517-e519 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Haemophilia : the official journal of the World Federation of Hemophilia
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
